Hiperton

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hiperton

Property Description
Active ingredient Sodium Chloride (NaCl)
Form Eye Drop (Ophthalmic Solution), Injection, Solution
Pharmacological class Electrolyte Replenisher / Miscellaneous Ophthalmic Agent
General Purpose Osmotic fluid withdrawal and electrolyte replenishment
Origin Inorganic compound (Synthetic preparation)

Hiperton is a specialized pharmaceutical preparation whose identity is based on the active substance Sodium Chloride (NaCl), which functions as a fundamental electrolyte. This medication is classified primarily as an Electrolyte Replenisher due to its role in restoring and maintaining the body's essential fluid balance, and is often manufactured as a hypertonic solution specifically positioned for targeted local and systemic intervention.


What Type of Medicine is Hiperton?

Hiperton is a medical preparation belonging to the pharmacological class of Electrolyte Replenishers or, when used topically, a Miscellaneous Ophthalmic Agent. The preparation is essentially a purified salt solution containing sodium (Na+) and chloride (Cl-) ions, which are critical for maintaining cellular function and fluid dynamics. The characteristic that defines Hiperton is its hypertonic concentration, meaning its salt solution is intentionally higher than the body's natural fluid tonicity. This high concentration dictates the drug’s distinct physiological action, a principle clinically utilized for managing fluid imbalances. Sodium Chloride is a fundamental component in therapeutic management, affirming its crucial role in medical care.


Composition, Forms, and Origin

The active ingredient in Hiperton is Sodium Chloride, an inorganic compound that is derived from mineral sources but is processed through pharmaceutical means, classifying it as a synthetic preparation. Hiperton is available in multiple dosage forms, including a sterile Injection, Solution for parenteral delivery and an Eye Drop (Ophthalmic Solution) for topical administration. While the systemic forms are typically single-ingredient products, the Eye Drop formulation is often differentiated by its inclusion of a specialized preservative and a specific hypertonic concentration (such as 5%) designed for ophthalmic stability. The solution's high-level composition requires the active substance to be dissolved in a solvent such as Water for Injection, ensuring quality standards are met for purity and safety.


The General Purpose of Hiperton's Osmotic Effect

The general purpose of Hiperton is tied directly to its powerful osmotic effect, which enables it to draw water out of tissues. The mechanism achieves fluid withdrawal by creating a difference in osmotic pressure, which can help relieve localized swelling or edema. When administered systemically, the medication's purpose is to achieve rapid fluid and electrolyte replenishment, supporting its role in stabilizing crucial physiological balances by restoring depleted levels of sodium and chloride ions.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Hiperton?

Possible Side Effects and Safety Information

Adverse reactions associated with Hiperton (Sodium Chloride) preparations are officially classified based on the route of administration, concentration, and potential impact on fluid and electrolyte balance, as documented in government regulatory sources. Frequency classification for many systemic effects is often Not Known or Not Defined.


Administration-Specific Reactions

The most commonly expected reactions are often local. The ophthalmic solution is associated with temporary stinging and eye irritation. Systemic administration (injection) may result in venous thrombosis, phlebitis, infection, or irritation at the infusion site, classified under General Disorders and Administration Site Conditions or Vascular Disorders.


Serious Systemic Adverse Reactions

High-level safety constraints documented in labeling primarily concern the risk of severe Metabolism and Nutrition Disorders. The most serious risks arise from rapid or excessive use, which can lead to significant fluid overload (Hypervolemia) resulting in conditions like pulmonary edema, or extreme electrolyte shifts. Severe Hypernatremia (excess sodium) is officially linked to serious neurologic consequences including seizures and coma.


Population-Specific Safety Considerations

The regulatory profile highlights specific cautions for certain patient groups. Individuals with severe renal impairment or Congestive Heart Failure are noted to be at an increased risk of sodium retention and fluid overload. Special caution is also mandated for pediatric and geriatric patients due to their potentially impaired ability to regulate fluid and electrolyte status.

Safety notes also indicate that rapid correction of sodium levels is associated with an increased risk of serious neurologic complications.

Overdose and Emergency Response

Overdose and when to seek help

The following information on Hiperton overdose is based strictly on authoritative governmental regulatory documents and prescribing information.

Overdose with Hiperton may result in specific clinical manifestations, primarily affecting the cardiovascular system and central nervous system. Documented presentations include significant hypotension (severely low blood pressure) and bradycardia (abnormally slow heart rate), along with symptoms such as dizziness and somnolence. Severe outcomes documented in regulatory sources can include circulatory collapse (shock) and secondary organ failure, such as acute renal failure.


Required Emergency Action

Immediate medical attention is mandatory upon known or suspected overdose. The official regulatory documents explicitly instruct users and caregivers to seek urgent medical services or contact a poison control center immediately following exposure. The drug must be immediately discontinued.

Management procedures described in the official label are supportive and symptomatic. These measures may include gastric decontamination, intravenous fluid administration to manage low blood pressure, and continuous monitoring of vital signs and electrocardiogram (ECG) to track heart function. Specific pharmacological antidotes are generally not listed; therefore, care focuses on treating the clinical signs of toxicity and maintaining physiological stability.

Population Considerations

Special considerations are noted for certain populations; for instance, patients with severe renal impairment may experience prolonged effects due to reduced drug clearance. Pediatric overdose may necessitate specialized care due to potential electrolyte disturbances.

Therapeutic Uses of Hiperton

What Hiperton Treats: Main Uses and Benefits

Hiperton is commonly used across therapeutic domains involving fluid and electrolyte management, and is considered relevant in contexts involving heightened systemic burden. Hypertonic solutions are utilized in the symptomatic management of situations where specific physiological applications are required.

The preparation is applied in conditions characterized by periods of heightened symptoms, including the management of severe hyponatremia and localized corneal edema. In clinical settings that involve acute or unstable symptom patterns, the treatment is used to address symptom clusters like confusion and weakness, providing support that helps ease the overall symptom burden. It is also relevant in conditions characterized by periods of heightened symptoms, like certain corneal dystrophies.

“It is commonly used to help with symptoms related to systemic imbalance and symptoms that interfere with daily functioning.”

This supportive treatment assists with maintaining functional stability during difficult episodes and contributes to easing the overall symptom load.


Quick Fact: Relief for Impaired Vision

Quick Fact: Relief for Impaired Vision from Corneal Swelling

Hiperton is applied when symptoms create noticeable physiological strain, primarily by helping to address blurred vision and reduced clarity which may become disruptive during flare-ups.

Regulatory References

  1. National Institutes of Health (NIH) StatPearls overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Hiperton?

Eligibility for Hiperton (Sodium Chloride) is strictly determined by regulatory authorities based on a patient's pre-existing fluid and electrolyte status and overall health.

Contraindications and Prohibited Use

Use of Hiperton is contraindicated and must be avoided in patients with hypernatremia (excessively high blood sodium), hypervolemia (excessive fluid volume), or a known hypersensitivity to any component of the formulation. The drug is also prohibited for patients in clinical states where the addition of sodium and chloride is formally deemed detrimental.

Restricted and Conditional Use

Use is restricted and requires extreme caution for populations with impaired function, as the risk of serious complications is greater. These populations include patients with severe renal impairment, congestive heart failure (CHF), or cirrhosis of the liver. Dosage selection must be cautious for geriatric patients due to the higher frequency of reduced organ function.

Age-Group and Special Status

While use is established in adults, regulatory agencies state that safety and effectiveness have not been established for the ophthalmic solution in the pediatric population. Systemic forms used during pregnancy are classified as Category C and should only be administered if clearly needed, with caution advised for nursing mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction documentation for Hiperton (Sodium Chloride) primarily focuses on pharmacodynamic effects related to fluid and electrolyte balance, as well as specific pharmacokinetic alterations for select co-administered medications.

Documented Interaction Patterns

The co-administration of Hiperton Injection with certain medicinal products requires careful consideration due to documented changes in physiological balance or drug exposure.

Interacting Substance/Class Official Interaction Outcome Regulatory Classification
Corticosteroids / Corticotropin Increased risk of hypernatremia and volume overload. Pharmacodynamic Interference
Specific Diuretics / Psychotropics Increased risk of developing hyponatremia. Pharmacodynamic Interference
Lithium Varies by Hiperton tonicity: May result in decreased serum lithium levels (via increased renal clearance) or increased serum lithium levels (via decreased renal clearance). Exposure Modification

Administration Requirements

Specific procedural restrictions are mandated in regulatory labeling. Hypertonic Hiperton Injection (3% or 5%) must not be mixed or administered with Whole Blood or Cellular Blood Components. For the ophthalmic solution, co-administration with other topical eye medications requires a separation interval of at least 5 minutes between drops. Cautions are noted for geriatric patients due to the higher frequency of decreased renal function, which may heighten the risk of adverse reactions related to sodium retention.

Mechanism of Action

How Hiperton Works

Hiperton functions as a selective inhibitor by physically occupying the L-type voltage-gated calcium channels found predominantly on the cell surfaces of vascular smooth muscle. This interaction prevents the normal influx of extracellular calcium ions ( Ca^2+) into the smooth muscle cells. The reduction of intracellular calcium directly interferes with the molecular signal required for muscle contraction, specifically disrupting the excitation-contraction coupling pathway.

This disruption promotes the relaxation of the arterial smooth muscle, a process known as vasodilation (artery widening). The resulting physiological consequence is a reduction in the overall systemic vascular resistance—the mechanical opposition to blood flow within the circulatory system—which lessens the force exerted against the vessel walls.

Dosage and Administration Information

Administration and Preparation

Hiperton is typically administered as a solution for injection or infusion. The preparation of the medication should be performed by healthcare professionals in a clinical setting. It is important to ensure that the solution is clear and free from visible particles before use.

General Considerations

The administration process involves specific clinical protocols to ensure the medication is delivered correctly. Healthcare providers monitor the patient during and after the procedure to evaluate the individual's response to the treatment.

Handling and Storage

Proper handling of the medication is necessary to maintain its stability. The product should be kept in its original packaging until the time of preparation to protect it from environmental factors. If the medication is intended for a single use, any remaining portion of the solution should be discarded according to standard medical waste procedures.

Monitoring During Use

While receiving Hiperton, patients are observed by medical staff. This monitoring allows for adjustments based on the clinical needs of the patient and ensures that the administration follows the established healthcare plan. Patients should inform their healthcare provider of any sensations or changes they experience during the administration process.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hiperton

Hiperton, a preparation based on hypertonic Sodium Chloride, was studied in several clinical areas. The research focuses primarily on the measured physiological responses to its topical and systemic administration. The evidence base includes randomized controlled trials (RCTs), systematic reviews, and observational studies, which help contextualize how patients reported their experience and how physiological markers were measured.


Evidence for Use in Corneal Edema (Eye Drop)

Studies of the hypertonic eye drop formulation research examined its effect in conditions associated with acute or disruptive episodes, such as swelling in the cornea. These trials typically included adult populations and monitored outcomes related to visual function and objective changes in eye structure, specifically changes in corneal thickness (Pachymetry).

Research highlights patterns measured during the study period, including what the studies monitored regarding corneal thickness following administration. Findings describe patterns observed in the studies where initial visual clarity was noted in studies evaluating the solution against control groups. Data for certain groups remain insufficient, particularly for pediatric populations.


Evidence for Use in Symptomatic Hyponatremia (Systemic Injection)

The use of the systemic injection was studied for conditions associated with acute or disruptive episodes of low sodium in the blood. Research primarily consists of short-term RCTs that focus on critically ill, hospitalized adult populations. These trials research examined a critical biomarker, the rate and magnitude of change in serum sodium (sNa) concentration, and outcomes related to systemic or functional imbalance.

Findings describe patterns observed in the studies where administration was followed by a documented, rapid shift in the sNa biomarker, which was associated with observed measurements of change in physiological markers. The evidence base primarily addresses the initial, short-term phase of care; long-term effects are not fully established.


What is Still Uncertain About Hiperton's Research Evidence

Across all indications, the evidence highlights what is known — and what is still uncertain. Evidence quality varies across studies, and the lack of comprehensive long-term outcomes remains a consistent gap. Sample sizes were modest in many trials, meaning generalizing findings may be limited. Research is ongoing to provide clearer guidance on administration protocols.

Key Studies & References

  1. NIH StatPearls: Hypertonic Saline Use in Hyponatremia

Frequently Asked Questions (FAQ)

Common questions about Hiperton (FAQ)


Q: Are there any specific foods I should avoid while on Hiperton?

Official information indicates that patients who are on a sodium-restricted diet should use caution with all products containing sodium, including drug preparations like Hiperton. While no specific foods are forbidden, official information emphasizes that any dietary guidance provided by a healthcare professional should be strictly observed to maintain a healthy fluid balance.


Q: Is Hiperton available as a generic medicine?

Hiperton’s active ingredient, Sodium Chloride, is classified as a long-established compound. According to regulatory status, this medicine is widely available in generic form on the market.


Q: Is it normal to have mild headaches when adjusting to Hiperton?

Headache is listed as a potential adverse reaction in some official documents, particularly when administered in certain clinical settings or when there are rapid shifts in the body’s electrolyte levels. Any persistent or severe headaches should be discussed with the prescribing healthcare professional.


Q: Can people with diabetes use Hiperton?

Official documents note that caution is required for patients with overt or subclinical diabetes mellitus if Hiperton is administered in a solution that contains dextrose (a form of sugar). The prescribing healthcare professional evaluates this risk based on the specific product formulation and the patient’s overall condition.


Q: Will Hiperton interfere with my ability to drive or operate machinery?

The official product label does not contain a specific driving warning. However, very serious complications from excessive or rapid use, such as seizures or coma resulting from severe hypernatremia (high sodium), could severely affect mental state and motor ability. Because severe complications could affect mental alertness, the capacity to operate machinery should be discussed with a healthcare professional.


Q: Is Hiperton a controlled substance?

No, Hiperton (Sodium Chloride) is an electrolyte solution used for replenishing fluids. It is typically classified by the Drug Enforcement Administration (DEA) as having no controlled substance schedule and is therefore not a controlled substance.


Q: Does Hiperton contain lactose or gluten?

The official labels for the sterile Injection and Ophthalmic Solution forms of Hiperton generally list water and pH adjusters as inactive ingredients. Lactose or gluten are typically not listed in these specific formulations.


Q: What is the risk of dizziness with Hiperton?

Dizziness is documented as a possible adverse reaction related to fluid or electrolyte shifts that the medication is designed to address. This possibility indicates that any occurrence of dizziness should be reviewed by a healthcare provider.


Q: Does Hiperton cause changes in mood or anxiety?

Changes in central nervous system function, including increased anxiety or restlessness, can be observed, particularly as a sign of underlying fluid and electrolyte imbalances (such as severe high sodium). These effects are typically documented in official labeling as being linked to the primary medical condition or severe complication.

How should Hiperton be stored and disposed of?

Storage and Handling Requirements

Hiperton (Sodium Chloride) must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). It is mandatory to protect the medication from freezing and excessive heat.

Storage Classification Requirement
Temperature Range 20 C to 25 C (Do not freeze)
Child Safety Keep out of the reach of children
Container Integrity Keep ophthalmic solutions tightly closed

Stability and Disposal

Injectable solutions are typically for single use only; any unused portion must be immediately discarded to maintain sterility. For disposal, unused or expired Hiperton must be handled in accordance with local regulations for pharmaceutical waste. Used needles or syringes must be placed in an appropriate sharps container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hiperton found in:

A-Z Index: